MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Janux Therapeutics (JANX) Ownership - Who owns Janux Therapeutics?
Profile
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
64
Web
https://www.januxrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.5B
P/E Ratio
N/A
Total Cash
658.03M
Projected Growth
N/A
Total Debt
23.43M
Revenue
13.05M
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash/Share
11.22
Total Debt/Equity
N/A
Revenue/Share
0.25 USD as % of share price
Fundamentals
JANX
Capitalization
3.5B
P/E Ratio
N/A
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash
658M
Total Cash/Share
11.22
Total Debt
23.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.25%
Revenue
13M
ROE
N/A
Book Value
656M
P/B Ratio
5.33
Cash Flow
N/A
Earnings
-1.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
52K
Current Ratio
38.80
Current Revenue Per Employee
5776.32
Dividends Per Share - Security
N/A
EBITDA
-83.88M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.19
Shares Held By Institutions
3.02B
Shares Outstanding - Current
58.6M
Total Liabilities
38.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
455.545
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
64
Web
https://www.januxrx.com